Entia Biosciences Inc (ERGO)
0.0002
0.00 (0.00%)
USD |
OTCM |
Nov 04, 16:00
Entia Biosciences Total Liabilities (Quarterly): 2.406M for Dec. 31, 2016
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2016 | 2.406M |
| September 30, 2016 | 2.009M |
| June 30, 2016 | 1.790M |
| March 31, 2016 | 1.432M |
| December 31, 2015 | 1.240M |
| September 30, 2015 | 0.9004M |
| June 30, 2015 | 0.8407M |
| March 31, 2015 | 1.055M |
| December 31, 2014 | 0.9872M |
| September 30, 2014 | 1.237M |
| June 30, 2014 | 1.924M |
| March 31, 2014 | 1.846M |
| December 31, 2013 | 1.581M |
| September 30, 2013 | 1.383M |
| June 30, 2013 | 1.315M |
| March 31, 2013 | 1.276M |
| December 31, 2012 | 1.111M |
| September 30, 2012 | 0.9816M |
| June 30, 2012 | 0.8767M |
| Date | Value |
|---|---|
| March 31, 2012 | 0.813M |
| December 31, 2011 | 0.6647M |
| September 30, 2011 | 0.7748M |
| June 30, 2011 | 0.6692M |
| March 31, 2011 | 0.6956M |
| December 31, 2010 | 0.7477M |
| September 30, 2010 | 0.627M |
| June 30, 2010 | 0.4355M |
| March 31, 2010 | 0.3987M |
| December 31, 2009 | 0.2054M |
| September 30, 2009 | 0.0676M |
| June 30, 2009 | 0.0551M |
| March 31, 2009 | 0.0647M |
| December 31, 2008 | 0.0584M |
| September 30, 2008 | 0.0015M |
| July 31, 2008 | 0.0015M |
| April 30, 2008 | 0.00 |
| January 31, 2008 | 0.00 |
| October 31, 2007 | 0.00 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ampio Pharmaceuticals Inc | 2.376M |
| FluoroPharma Medical Inc | 10.51M |
| Evolutionary Genomics Inc | 7.946M |
| Xeno Transplants Corp | -- |
| Regenerx Biopharmaceuticals Inc | 3.931M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.4391M |
| Shareholders Equity (Quarterly) | -1.967M |